Diagnostic clinics

Our breast service is led by a team of experienced consultants and is designed around rapid access pathways that cover every stage and all modalities from early detection to advanced therapies.  This includes a same-day, triple diagnostic assessment service for people concerned about their breasts with seamless progression from comprehensive diagnosis to breast cancer treatment if needed.

Our clinical protocols are based on the best practice of centres of excellence across the world and include advanced and innovative techniques as standard, alongside modern therapeutic approaches. Together with a growing healthcare professional community in the UK, we are implementing these evidence-based treatment protocols across our network of specialist outpatient oncology centres and designing new ways to improve patient outcomes.

Diagnostics
Flexible appointments

Chemotherapy
Immediate

Radiotherapy
Same-day treatment for urgent, two days for palliative and five days from planning scan for radical.

Patients have full access to a one stop triple assessment service.

We use the latest digital mammography techniques to provide fast, reliable results and peace-of-mind to symptomatic and non-symptomatic patients.

Triple assessment diagnostics

• Consultant Radiologist-led breast ultrasound
• Digital mammograms including 3D tomography
• Core needle biopsy
• Fine-needle aspiration
• Routine and specialised blood tests

A full genetic testing service

• BRCA1 and BRCA2 screening and counselling

• Flexible appointments often within 24 hours. Find your nearest GenesisCare centre for more information about our specialist outpatient cancer services that are available on-site or at partner hospitals.

To refer a patient to the One Stop Breast Clinic, please visit this page

If a biopsy is required, the results will be made available within five days of the biopsy at a follow-up appointment with the consultant. A copy of these results will also be shared with the patient’s GP.

All biopsy results are discussed at a GenesisCare Breast Multidisciplinary Team (MDT) meeting, which includes surgeons, radiologists, pathologists and oncologists where treatment plans are discussed and appropriate action is agreed.

If no evidence of breast cancer is found, the results are discussed with the patient in detail together with any advice or reassurances. If the biopsy does show the presence of a cancer, we are able to discuss with the patient the next steps required to move towards appropriate treatment.

Seamless access to a comprehensive diagnostic pathway

Following a positive diagnosis at a One Stop Breast Clinic, our rapid access pathways include all diagnostic modalities, including MRI and PET/CT as required, to allow us to make decisions with the patient about potential treatment pathways, and to start that treatment in the most timely manner.

The aim of this multi-modality approach is to ensure prompt diagnosis and commencement of treatment – optimising the outcome for every patient following their cancer diagnosis.

Advanced diagnostics

• Contrast-enhanced mammography
• Stereotactic biopsy
• MRI breast
• PET/CT

We are ready to start treatment immediately

We provide fast access to our comprehensive cancer treatment pathways, with treatment often starting within days of diagnosis. We will seamlessly arrange surgery and acute admissions at our partner hospitals where needed to ensure a continuous patient experience. Our centres offer many advanced radiotherapy techniques, private chemotherapy suites and all chemo and radiotherapy patients are offered wellbeing therapies such as acupuncture and counselling, through the Penny Brohn UK charity, and exercise medicine at no additional cost to the insurer or the patient – all under the care of a consultant oncologist.

Advanced radiotherapy as standard, including:

• Volumetric modulated arc therapy (VMAT)
• Image guided radiotherapy (IGRT)
• Surface guided radiotherapy (SGRT)
• Deep inspiration breath hold (DIBH)
• Tattoo-free treatment
• Stereotactic ablative radiotherapy (SABR)

Innovative pathways, including:

• Sequence reversal (pre-operative radiotherapy)
• Partial breast radiotherapy
• Simultaneous integrated boost radiotherapy

Chemotherapy

• Full range of systemic anticancer therapies
• Private, individual chemotherapy suites
• One-to-one nursing and 24/7 on-call triage
• iQemo prescribing and management platform
• Genomic profiling

Wellbeing

• Penny Brohn UK wellbeing programme
• Exercise medicine

We operate as multidisciplinary teams (MDTs), which include surgeons, radiologists, pathologists and oncologists. The team reviews all biopsies alongside the clinical, mammogram and ultrasound investigations to ensure appropriate action is taken.

Our consultants

Our services and consultants are recognised by all leading private medical insurance providers, including Bupa, AXA PPP, Aviva and Vitality. We can support patients with insurance approvals. Patients also have the option to self-pay for their consultations, diagnostic tests and treatments.

Bilateral mammography from £210
Ultrasound from £290

From early screening to advanced treatments, our centres offer a range of modalities on-site and with partner hospitals. Find your nearest centre for more details.

Find a centre

UrologyHub provides a single point of referral for men who are symptomatic or concerned and require a consultation or diagnostic assessment for problems related to the urinary tract or male reproductive system. Our aim is to provide patients with rapid access to a urologist with an appropriate specialism together with any required diagnostic investigations on the same day. Further investigations and treatment will be seamlessly delivered through pre-existing pathways.

Our clinics are located in our state-of-the-art specialist outpatient centres with access to a full multidisciplinary team for a fast and professional urology service. As the service is provided under GenesisCare, there is a clear and comprehensive pathway for patients with a cancer diagnosis who choose private treatment.

• Flexible appointments
• Consultant appointment
• Diagnostic tests
• Results or discussion
• Follow-up
• Diagnostics
• Discharge or treatment pathway

UrologyHub is a consultant-led service providing a single point of referral for the diagnostic assessment of problems related to the urinary tract or male reproductive system.

Any symptomatic or concerned male patient can see a consultant in a specialist urology clinic setting and undergo any necessary diagnostic assessments during the same appointment, or soon after. Patients can be referred by their GP to a urologist with the appropriate specialism or, if they choose to self-refer, they will be triaged by a urology nurse and referred to an appropriate urologist.

We provide all standard tests including blood tests, cytology, urinalysis and urodynamics (a full list of services is available on request). These will normally be carried out on the same day as the initial consultation appointment and we aim to discuss results or feed back to the patient on the same day – before they leave the clinic.

Our aim is to provide a fast diagnosis and expert opinion, together with any further investigative or treatment pathway. Patients are supported by a multidisciplinary team during their initial consultation and any further appointments to ensure a smooth transition from investigation to treatment, if needed.

UrologyHub diagnostics

• Consultant examination
• Bladder scan
• PSA blood test
• Blood urea nitrogen, creatinine, eGFR
• General health test
• I-PSS (International Prostate Symptom Score)
• Kidney function tests
• Renal tract and abdominal ultrasound
• Ultrasound
• Urine cytology
• Urinalysis and urine microscopy and culture
• Urinary flow assessment & post micturition bladder volume scan assessment

Flexible appointments often within 24 hours. Clinics Monday to Friday at varying weekdays and evening times. Find your nearest GenesisCare centre for more information about our specialist outpatient cancer services that are available on-site or at partner hospitals.

To refer a patient please provide information about any tests and or scans that have already taken place.

Patients requiring further investigation or treatment have direct access to our comprehensive diagnostics and advanced treatments. Patients will be offered a follow‑up appointment to discuss their diagnosis and what the next steps are, including a personalised treatment plan if required.

We use the latest modalities, including specialist advanced diagnostics, which, depending on the symptoms and potential condition, include imaging such as mpMRI and PSMA PET-CT scans for the diagnosis of prostate cancer. All biopsies for suspected cancers are reviewed at a multidisciplinary team meeting which includes surgeons, radiographers, oncologists, pathologists and specialist nurses.

Advanced diagnostics

• Flexible cystoscopy
• Ultrasound fusion
• Transperineal targeted prostate biopsy
• mpMRI (multiparametric MRI) scan
• CT scan (with contrast)
• PSMA PET-CT scan
• Urodynamics

Patients diagnosed with cancer can be referred directly to the GenesisCare oncology service, a world-class treatment pathway for urological cancers encompassing advanced radiotherapy and chemotherapy for management of all stages of cancer.

We are at the forefront of innovation in radiotherapy and offer advanced and innovative techniques as part of comprehensive pathways of diagnosis and care for urological cancers. These include the latest-generation linear accelerators at each of our centres and the UK’s first MRIdian MR linacs at our centres in Oxford and London for stereotactic ablative radiotherapy. Through our Urology Reference Group, we can provide second opinions and innovative, proven treatment options, with therapy starting within days of diagnosis, or sooner, if clinically indicated.

Radiotherapy

• Volumetric modulated Arc therapy (VMAT)
• Palliative VMAT radiotherapy – within 2 days
• Surface-guided radiotherapy (SGRT)
• Spacers
• Stereotactic ablative radiotherapy (SABR)
• MRIdian, MR-guided radiotherapy
• ¹⁷⁷Lutetium PSMA therapy – for metastatic prostate cancer
• Radium-223 therapy – for advanced prostate cancer

Medical oncology

• Chemotherapy
• Hormone therapy
• Bisphosphonates
• Immunotherapy

Surgery (at partner hospitals)

Wellbeing

Where available, anyone receiving prostate cancer treatment at GenesisCare will be offered supporting therapies to treat ‘the whole patient’, as well as their cancer

• Penny Brohn UK wellbeing therapies, including counselling and acupuncture
• Exercise Medicine – effective in improving treatment tolerance, building muscle mass and reducing cancer-related fatigue, among many other health-related benefits

UrologyHub is consultant-led, comprising of nationally recognised urology surgeons supported by a dedicated on-site team. These surgeons have pioneered many innovative treatments and together provide a broad service, such that patients can also be referred to an appropriate specialist at a convenient time.

We operate as multidisciplinary teams (MDTs), which includes surgeons, radiologists, radiographers, pathologists and oncologists. This ensures the highest levels of clinical governance through a process of peer review.

Our consultants

Our services and consultants are recognised by all leading private medical insurance providers, including Bupa, AXA PPP, Aviva and Vitality. We can support patients with insurance approvals. Patients also have the option to self-pay for their consultations, diagnostic tests and treatments.

• Consultation from £225
• Ultrasound from £290
• CT scan from £400
• MRI from £450

From early screening to advanced treatments, our centres offer a range of modalities on-site and with partner hospitals. Find your nearest centre for more details.

View centres

• Pre-referral discussion with a haematologist – free service to GPs
• Rapid Access Haematology Service appointments available the same day as referral or next day
• Same-day imaging and results
• Same-day diagnostics (within 48 hours for telehealth consultations)
• Locations: Milton Keynes, Oxford and Windsor
• Patients with private medical insurance will need a GP referral or pre-authorisation
• Self-pay patients do not need a GP referral

Our Rapid Access Haematology services are consultant-led, multidisciplinary and multi-modality for the assessment, diagnosis and treatment of patients referred from a primary care setting.

The service has been designed for referring doctors to provide easy access to expert advice from a consultant haematologist and fast referral to a comprehensive diagnostics pathway where needed at our Rapid Access Haematology service.

As the UK’s leading private cancer provider, GenesisCare provides world-class treatment including chemotherapy and advanced radiotherapy, within our specialist private oncology centres. Our aim is to support our referring clinicians by providing pre-referral advice, reassurance to patients and a differential diagnosis of a more serious condition.

Haematological cancers can be challenging to diagnose, but our dedicated haematology MDT approach will improve the life outcome for these patients by facilitating fast, efficient access to an optimum treatment pathway.

Same-day imaging and rapid access to world-class haematological cancer care

– GenesisCare

Patients visiting the Rapid Access Haematology Service will undergo:

• A face-to-face consultation with a consultant haematologist, or
• Telehealth consultation (via telephone or online)

Any necessary diagnostic tests and scans will be conducted at the centre on the same day as their consultation or within 48 hours of their telehealth consultation, including, as needed:

• Same-day diagnostics (within 48 hours for telehealth consultations)
• Comprehensive blood tests
• Ultrasound scan with or without biopsy
• CT scan
• Whole body MRI
• Bone marrow aspiration (performed onsite under local anaesthetic)

Imaging results are returned on the same day and pathology within 48 hours so patients who need to have further tests and treatment can do so without delay. We will also share results with the referring doctor. Any patients with an alternate diagnosis will be referred to the appropriate care team within GenesisCare or back to their primary care team as needed. In the event of a cancer diagnosis your patient will undergo a full case review by the GenesisCare haematology multidisciplinary team via our regular eMDT. They will agree further assessment, such as FDG PET/CT and genomic profiling, and treatment as needed.

You can download our haematology diagnostic pathway here.

Following a cancer diagnosis, treatment will be planned to start within seven days.

Patients may typically present with symptoms and/or an abnormal blood test result. Symptoms include:

• Enlarged lymph node present for over four weeks with Epstein-Barr virus, cytomegalovirus, HIV and toxoplasmosis excluded
• Persistent fever with no other cause found, persistent drenching night sweats or unexpected weight loss
• Splenomegaly in the absence of liver disease
• Unexplained fatigue
• Unexplained bone pain

Abnormal blood test results include:

• Excess light chains and / or finding of paraprotein
• Raised lymphocyte count present on repeat testing
• Persistently raised platelet or neutrophil count in the absence of an underlying infection or inflammatory disorder (N.B. smoking is a frequent cause of mild persistent neutrophilia)
• Pancytopenia
• Other cytopenias which are persistent and / or progressive (N.B. ethnic neutropenia is a common cause of mild neutropenia in people from African descent)
• Anaemia (including iron deficiency/B12 deficiency)
• Raised ferritin with elevated transferrin saturation (haemochromatosis)
• Raised venous haematocrit/polycythaemia

If you are unsure if a full referral to our Rapid Access Haematology Service is required, you can get advice from a consultant haematologist (at no cost to the patient or their insurer) by completing a pre-referral.

Make a referral or request pre-referral advice from a consultant haematologist.

Our team includes experienced consultant haematologists local to each centre so patients can receive their treatment nearby. If necessary, patients can choose to see a consultant with a particular specialism and this can be arranged at another centre within our GenesisCare network.

Dr Moez Dungarwalla
Consultant haematologist
MBBS, MRCP, FRCPath, PMETB
Special interest: Anaemia, leukaemia, lymphoma, myeloma, myelodysplastics syndrome (MDS), myeloproliferative disorders (MPDS) and thrombophilia
NHS trust: Milton Keynes University Hospital NHS Foundation Trust

Dr Graham Collins
Consultant haematologist
MBBS, MA, MRCP, FRCPath, DPhil
Special interest: Haematology, lymphoma and other lymphoproliferative disorders
NHS trust: Oxford University Hospitals NHS Foundation Trust

Dr Toby Eyre
Consultant haematologist
MBChB (Hons), DipMedEd, MRCP (UK), FRCPath (UK), MD (University of Newcastle)
Special interest: Lymphoma and lymphoproliferative disorders, chronic lymphocytic leukaemia (CLL)
NHS trust: Oxford University Hospitals NHS Foundation Trust

Dr Chris Hatton
Consultant haematologist
MB, BChir, FRCPath, FRCP
Special interest: Haematology and chronic lymphocytic leukaemia (CLL), lymphoma and lymphoproliferative disorders
NHS trust: N/A

Dr Jaimal Kothari
Consultant haematologist
MA, BM BCh, MRCP, FRCPath
Special interest: Haematology, myeloma, lymphoma and chronic lymphocytic leukaemia (CLL)
NHS trust: Oxford University Hospitals NHS Foundation Trust

Dr Karthik Ramasamy
Consultant haematologist
MBBS, PhD, MRCP, FRCPath
Special interest: Haematology, myeloma, other plasma cell dyscrasias, stem cell transplantation
NHS trust: Oxford University Hospitals NHS Foundation Trust

Professor Anna Schuh
Consultant haematologist
MD, PhD, MRCP, FRCPath
Special interest: Haematology, chronic lymphocytic leukaemia (CLL)
NHS trust: Oxford University Hospitals NHS Foundation Trust

Dr Jaimal Kothari
Consultant haematologist
MBBS, MRCP, FRCPath, PMETB
Special interest: Special clinical interest in myeloma, lymphoma, chronic lymphocytic leukaemia (CLL) and general haematology.

• Immediate referral to GenesisCare pathway
• Recognised by all private medical insurers
• Funding advice and self-pay options
• Support with transition to alternative service

We provide fast access to our comprehensive treatment pathways, with surgery and acute admissions arranged with our partner hospitals where necessary. Our centres offer many advanced external beam radiotherapy techniques and private chemotherapy suites, with a full range of systemic anti-cancer treatments (SACTs).

Patients receiving radiotherapy or chemotherapy at GenesisCare will also receive wellbeing and exercise medicine (where available) at no cost to them, as part of our whole patient approach to supporting them through this potentially life-changing experience.

During the pandemic we have modified our treatment protocols in line with advice from disease forums for professionals, the Royal Colleges and Royal College of Radiologists, to ensure our patients can continue to receive cancer treatment without delay.

• Myeloma
• Lymphoma (including non-Hodgkin and Hodgkin)
• Leukaemia
• Myeloproliferative disorders
• Early stage cancerous blood disorders – monoclonal gammopathy (MGUS), clonal haematopoiesis of indeterminate potential (CHIP), monoclonal B lymphocytosis (MBL)

Our services and consultants are recognised by leading private medical insurers, including Bupa, AXA PPP, Aviva and Vitality. We can support patients with gaining insurance approvals. Patients have the option to self-pay for their consultations, diagnostic tests and treatments.

MRI from £450

Ultrasound from £290

Download our handy referral reference for our Rapid Access Haematology Service

• Appointments available within 24 hours (of referral)
• Same-day scope and/or biopsy
• Ultrasound or biopsy in 72 hours (results in five days)
• Location: Oxford
• Emergency admissions
• Patients with private medical insurance will need a GP referral or pre-authorisation
• Self-pay patients do not need a GP referral

Contact our Oxford centre on 01865 237 700 or email oxford.admin@nhs.net

Our Rapid Access Head and Neck diagnostics pathway is a consultant-led, multidisciplinary and multi-modality service for the rapid assessment and treatment of patients referred from a primary care setting.

The service has been designed with leading head and neck experts to provide speed of access and ease-of-referral to comprehensive diagnostics and world-class treatment within our specialist private oncology centres. Our aim is to support our referring clinicians by providing reassurance, early detection of a more serious condition and easy access to an optimum treatment pathway.

Although head and neck cancers account for less than 5% of referred cases, they can be fast growing and so early diagnosis and treatment without unnecessary delays is paramount. Our dedicated MDT approach will improve the quality of life outcome for these patients.

Same-day imaging and rapid access to world-class head and neck cancer care

– GenesisCare

Symptomatic patients accessing our Rapid Access Head and Neck Service will undergo a face-to-face appointment with a consultant ENT surgeon (patients with a neck mass may be asked to have an ultrasound prior to their appointment).

Patients will then be referred for appropriate diagnostic tests, which may typically include:

Same-day – scope or imaging

• 3T MRI
• Nasopharyngoscopy (performed during consultation)

Biopsy – within 72 hours

• Ultrasound
• Ultrasound biopsy

Blood tests – including

• FBC
• U&E
• Liver function test
• Thyroid function
• Clotting

Results from an ultrasound biopsy are available within five days and are provided at a follow-up consultation. These results are shared with you as the referring GP. In the event of a cancer diagnosis your patient will undergo a full case review by the GenesisCare head and neck multidisciplinary team via our weekly eMDT. They will agree further assessment and treatment.

Further investigations and eMDT review

• CT
• PET/CT
• Diagnostics under GA at GenesisCare partner hospital

Full results and eMDT outcome in 72 hours

Following a cancer diagnosis and completion of all investigative procedures, treatment will be planned to start within a few days. During this time patients will be given access to our speech and language therapist and dietitian and an appropriate care plan will be put in place.

Evidence supports that higher cancer stage and worse survival is seen with longer delays, and the unfavourable oncological and emotional outcome could be devastating for patients.

As well as state-of-the-art diagnostics and treatments, we provide a solid multidisciplinary approach, with a specialist nurse, dietitian, speech and language therapist, and psychological support during treatment. This is essential to providing the most appropriate treatments without interruptions.

Although less than 5% of patients will be diagnosed with cancer, all patients referred will be offered appropriate treatment, including supporting speech and language therapy (SLT) and dietitian intervention

– GenesisCare

Patients may present with any unexplained head and neck symptoms including:

• Facial nerve weakness
• Facial numbness (paraesthesia)
• Goitres
• Neck lumps (mass)
• Nasal blockages (obstruction)
• Feeling of a lump on the throat
• Reflux
• Swallowing issues (dysphagia)
• Voice hoarseness/voice change (dysphonia)
• Swelling in the throat, including tonsil
• Persistent mouth ulcers
• White/red patches in the mouth
• Unexplained teeth problems
• Persistent pain in the head, neck or ear

Our consultant team at Oxford comprises:

Professor Stuart Winter
Consultant ENT, head and neck surgeon
MD MB ChB BSc FRCS(ORL-HNS)
Special interest: Lumps in the neck, cancer of the head and neck, salivary gland problems, swallowing problems, voice and sinus problems
NHS trust: Oxford University Hospitals NHS Foundation Trust

Mr Priy Silva
Consultant ENT, head and neck surgeon
Special interest: ENT, benign and malignant head and neck problems
MB ChB, DO HNS, MRCS, FRCS, MD
NHS trust: Oxford University Hospitals NHS Foundation Trust

Mr Satheesh Prabhu
Consultant oral and maxillofacial surgeon
MBChB, FDSRCS (Eng), FRCS (Ed), FRCS (Ed) (OMFS)
Special interest: Head and neck cancer, oral rehabilitation including dental/facial implants, Zygoma implants and salivary gland disease
NHS trust: Oxford University Hospitals NHS Foundation Trust, Royal Berkshire NHS Foundation Trust

Dr Sileida Oliveros
Consultant clinical oncologist
MBBS, MRCP (UK), FRCR, MD
Special interest: Breast and head and neck
NHS trust: Oxford University Hospitals NHS Foundation Trust

Dr Ketan Shah
Consultant clinical oncologist
BM, BCh, MA (Cantab), BMChB (Oxon), MRCP, PGDip Oncology, FRCR, DPhil Radiobiology (Oxon)
Special interest: Breast and head and neck
NHS trust: Oxford University Hospitals NHS Foundation Trust

Dr Nicola Dallas
Consultant clinical oncologist
MBChB, MRCP, FRCR
Special interests: uro-oncology (prostate, bladder, kidney), germ cell tumours (testicular), head and neck and thyroid cancer
NHS trust: Royal Berkshire NHS Foundation Trust

Dr Fintan Sheerin
Consultant neuroradiologist
MA, MB, BChir, MRCP, FRCR
Special interest: Conditions of the CNS, spine, head and neck region
NHS trust: Oxford University Hospitals NHS Foundation Trust

GenesisCare patients are also given access to a Penny Brohn wellbeing consultant to support them emotionally through their cancer journey with counselling, as well as to provide therapies such as reflexology and acupuncture.

• Immediate referral to GenesisCare pathway
• Recognised by all private medical insurers
• Funding advice and self-pay options
• Support with transition to alternative service

We provide fast access to our comprehensive treatment pathways, with a full range of bespoke surgical solutions and a multidisciplinary team to achieve the best oncological outcome and preserve function as well as acute admissions and gastrostomy arranged with our partner hospitals where necessary.

At GenesisCare, our centres offer many advanced external beam radiotherapy techniques, including volumetric modulated arc therapy (VMAT) as standard, with daily image-guided radiotherapy online imaging. We use a faceless shell so that we can use surface-guided radiotherapy (AlignRT) to monitor any movements of the patient, providing a favourable patient experience.

We also provide a full range of systemic anti-cancer treatments (SACTs), with dedicated chemotherapy suites and access to the latest-generation drugs as well as antiemetics and other supportive medications.

Every patient receiving radiotherapy or chemotherapy at GenesisCare will also receive wellbeing therapies at no cost to them, as part of our whole patient approach to supporting them through this potentially life-changing experience.

Patients will receive bespoke speech therapy and dietary advice post-treatment to support their rehabilitation.

You can download our head and neck pathway here.

During the pandemic we have modified our treatment protocols in line with advice from the Royal Colleges and Royal College of Radiologists, to ensure our patients can continue to receive cancer treatment without delay. Find out more

• Laryngeal cancer
• Mouth cancer
• Nasal cavity cancer
• Nasopharyngeal cancer
• Thyroid cancer
• Salivary gland cancer
• Throat cancer
• Oropharyngeal cancer (tonsil)
• Hypopharyngeal cancer

Our services and consultants are recognised by leading private medical insurers, including Bupa, AXA PPP, Aviva and Vitality.  We can support patients with gaining insurance approvals. Patients have the option to self-pay for their consultations, diagnostic tests and treatments.

Download our handy referral reference for our Head and Neck Service

Our Rapid Access Gynaecology Diagnostic and Treatment Clinics at our specialist oncology centres are an ambulatory service, offering same-day assessment of gynaecological symptoms and state-of-the-art diagnostic and treatments within an outpatient setting.

We provide a single point of referral to high-quality care and a comprehensive service for the assessment of cervical, endometrial, ovarian and vulval conditions. We offer fast diagnosis and seamless access to comprehensive treatment if necessary.

Symptomatic or concerned patients can see a consultant in a specialist gynaecology clinic and undergo any necessary diagnostic assessments on the same day.

Ultrasound

Transvaginal/transabdominal ultrasound scan – for endometrial thickness and ovarian morphology assessment

Diagnostic/therapeutic drainage of ascites with ultrasound guidance

Ultrasound paracentesis for diagnostic and therapeutic drainage of ascites – for ovarian cancer symptoms

Blood tests

Serum CA125 – for symptoms that suggest ovarian cancer

Carcinoembryonic antigen (CEA)

Hysteroscopy

Hysteroscopy with directed biopsy

Hysteroscopy with resection of polyps

Hysteroscopy with resection of fibroids

Hysteroscopic endometrial ablation

IUDs

Fitting Mirena intrauterine device (IUD) – for hyperplasia or patients unsuitable for hysterectomy

Colposcopy

Cervical screening with HPV and cytology

Colposcopy with diagnostic biopsy

Colposcopy with therapeutic biopsy (LLETZ)

Vulvoscopy with diagnostic biopsy

Our aim is to provide answers quickly and ensure patients are referred to the appropriate pathway without delay.

Biopsies will be conducted under local anaesthetic, using proven best practice techniques of pain management and in line with patient preferences.

Our Rapid Access Gynaecology Diagnostic clinics are consultant-led supported by one of our clinical nurse specialists.  We operate a multidisciplinary team (MDT) approach. Our gynaecology clinical teams can access peer review from surgeons, radiologists, radiographers, pathologists and oncologists where needed. See a full list of clinicians with practising privileges at our centres.

Our Rapid Access Gynaecology Clinics have been equipped with the latest world-class gynaecological diagnostic modalities for superior patient comfort and reliability of results.

Our GenesisCare outpatient centres deliver world-class services for patients, with next-generation equipment to ensure access to the most advanced radiotherapy treatments. At our outpatient centre in Portsmouth, as well as upgrading the consultation rooms and radiotherapy prep room, an Elektra Versa HD linear accelerator has been installed.

We are proud that each of our centres hold the Macmillan Quality Environment Mark (MQEM) and are rated good or excellent by 95% of patients.

We are recognised by all leading providers of private medical insurance (AXA, Bupa, PPP, Vitality). A GP letter may be required depending on insurance provider.

We also offer self-pay options and prices are available from the centres.

Open to treat without delay

– GenesisCare

We are open to treat without delay throughout the pandemic. Our centres are stand-alone with low footfall. See our Covid-19 policy here.